Acne

In part 1 of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

Researchers conducted a pooled data analysis using previous study data to determine the cream’s efficacy in patients ages 12 and up.

Emmy Graber, MD, MBA, covered it all in her Winter Clinical Miami talk, offering take-home pearls via patient case studies.

Hilary Baldwin, MD, shares treatment updates and recommendations for acne and rosacea at South Beach Symposium.

A new study also explores why the incidence of acne vulgaris is higher in girls than boys.

Experts at Maui Derm Hawaii offer the latest findings and research in treating acne vulgaris in adolescents.

A poster presentation from Winter Clinical Hawaii evaluated the impact of acne vulgaris on emotional and social functioning among pediatric patients.

Dr Leon Kircik, comments on the impact the multiple formulations of isotretinoin had on acne care; and highlights the efficacy differences between generic vs brand formulations.

Leon Kircik, M.D., discusses the indication of isotretinoin for use in patients suffering from acne, highlighting the difference between high and low dose administration needs.

An expert in acne management shares her insight into the patient characteristics a provider needs to consider when assessing the risk/benefit of a therapeutic agent for the management of acne.

Dr Zoe Diana Draelos discusses the role of ancillary skin care products in the management of acne and stresses the importance of setting patient expectations.

Zoe Diana Draelos, MD comments on the importance of tailoring acne treatments based on disease severity and the ability to target key acne pathogenesis factors.

Truncal acne, or back acne, is a common skin condition of the pilosebaceous unit, with a global lifetime prevalence of 70% to 85%.

Hilary Baldwin, M.D., shares her hopes for the future of acne treatment and provides her practice pearls from a panel discussion surrounding the management of patients suffering from acne.

An expert in acne management shares her insight on the current needs and the role of consensus guidelines in the management of patients suffering from acne.

Dr Hilary Baldwin discusses her treatment considerations and approach in the management of patients with mild to moderate acne, highlighting the benefit of combination therapy.

Hilary Baldwin, M.D., comments on the impact of the recent approval of clascoterone cream 1% in the topical acne armamentarium of patients suffering from acne.

CBD therapy has had positive outcomes in other inflammatory conditions.

Newly approved laser treatments can be an effective option for the treatment of this common skin disorder.

Accure’s system is the first 1726nm-based laser device with both FDA and CE Mark clearances.

Numerous adverse effects are associated with standard-dose isotretinoin.

Patient-reported outcome measures ensure patients' experiences are documented during new treatments.

Neal D. Bhatia, MD, discusses the nuances of photodynamic therapy in a session at Fall Clinical in Las Vegas, Nevada, October 20-23.

Understanding the main causes and staying current on recommendations and treatments will help reduce patient rates of the condition.

New studies explore how stress plays a large role in triggering acne.

Drs Joshua Zeichner, MD, and Mona Gohara, MD, provide take-home messages to providers treating patients with acne.

Expert dermatologists discuss different types of moisturizers and how to properly select a moisturizer.

Joshua Zeichner, MD, and Mona Gohara, MD, discuss adherence issues and adverse effects related to topical treatments for acne vulgaris.

Joshua Zeichner, MD, and Mona Gohara, MD, discuss what ingredients make an ideal moisturizer.

Joshua Zeichner, MD, and Mona Gohara, MD, discuss different types of lipid-free cleansers and how to properly select a cleanser.